Lymphedema: A Significant Complication Among Cancer Patients in Kinshasa, Democratic Republic of the Congo
Journal of Cardiovascular and Cardiology · 31.12.2026 · 1-6
DOI: 10.61440/jcc.2026.v4.73 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular and Cardiology, online erschienen am 31.12.2026. Verfasst von Muzembo Ndundu Jean.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Cancer is a major global public health concern. In resource-limited countries, cancer-related mortality is particularly high, prompting healthcare teams to pay special attention to this issue. Among the various types of cancer, breast cancer is currently the leading cause of cancer-related death in women. Breast cancer is associated with numerous complications, one of which—lymphedema—significantly impairs patients’ autonomy. Materials and Methods: Data were collected through two studies conducted during the periods 2016–2018 and 2022–2023, respectively. The first study took place in several university and general hospitals in the city of Kinshasa, while the second was conducted at a hospital specializing in cancer treatment. The data analyzed were derived from both the examination and follow-up of subjects and the medical records of patients who sought care at the targeted hospitals. The analysis of these records aimed to: - Identify the types of cancer diagnosed; - Determine the frequency of cancer-related complications, specifically the prevalence of lymphedema associated with breast cancer; - Analyze the management of breast cancer and its complications, with a focus on the treatment of breast cancer-related lymphedema.
Results
In the study conducted across the general and university hospitals, 60 cases were identified over the three years from 2016 to 2018. The subjects’ ages ranged from 10 to 89 years. There was a higher proportion of women than men (73% vs. 27%). Thirty-two subjects were over the age of 50. These are patients who underwent rehabilitation for various cancer-related complications. In this sample, breast cancer cases account for 43.3%. The remaining cases consist of prostate cancer (26.7%), lung and respiratory tract cancers (16.7%), and digestive tract cancers (13.3%). Frequently observed complications in these patients include lymphedema, pain, and physical deconditioning. In the second phase of the study, 129 cancer cases were diagnosed within a specialized oncology facility. Females were predominant (89 vs. 40). The majority of subjects were over 50 years of age (63%). Several types of cancer were identified within the sample, with breast cancer being the most common (37 cases, 28%). Various complications were observed during the course of treatment for the cases monitored and the medical records analyzed. An analysis of the two samples reveals that the prevalence of lymphedema was 92% in 2022–2023 and 43.3% in 2016–2018.
Conclusion
Vascular disorders, such as lymphedema and other forms of venous edema, are significant complications of cancer. Lymphedema appears to be particularly associated with breast cancer. These vascular complications generally arise as a result of the progression of the cancer or the treatments administered to address it. It is therefore essential that healthcare professionals remain attentive to all potential complications, ensuring comprehensive and holistic care for individuals with cancer, particularly those with breast cancer.
Zitieren
APA
Jean, M. N. (2026). Lymphedema: A Significant Complication Among Cancer Patients in Kinshasa, Democratic Republic of the Congo. Journal of Cardiovascular and Cardiology, 1-6. https://doi.org/10.61440/jcc.2026.v4.73
Vancouver
Jean MN. Lymphedema: A Significant Complication Among Cancer Patients in Kinshasa, Democratic Republic of the Congo. Journal of Cardiovascular and Cardiology. 2026:1-6. doi:10.61440/jcc.2026.v4.73
BibTeX
@article{Jean2026,
author = {Jean, Muzembo Ndundu},
title = {Lymphedema: A Significant Complication Among Cancer Patients in Kinshasa, Democratic Republic of the Congo},
journal = {Journal of Cardiovascular and Cardiology},
year = {2026},
pages = {1--6},
doi = {10.61440/jcc.2026.v4.73}
}
EUVIMED